#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nasopharyngeal cancer Follicular lymphoma Infantile apnoea Measles Myelodysplastic syndrome Hypotransferrinaemia Cholestatic pruritus Neuroendocrine cell hyperplasia of infancy Langerhans' cell histiocytosis Aicardi-Goutieres syndrome Malformation venous Hormone-dependent prostate cancer Uterine leiomyosarcoma Haematological malignancy Neurotrophic keratopathy More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Life with Disease Brain stem glioma – Trials in Disease Hereditary neuropathic amyloidosis – Trials in Disease Burkitt’s lymphoma – Trials in Disease Focal segmental glomerulosclerosis – Treatment Activated PI3 kinase delta syndrome – Trials in Disease Rhabdoid tumour – Diagnostics Turner’s syndrome – Trials in Disease Marginal zone lymphoma refractory – Life with Disease Gaucher’s disease type III More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cenegermin Ict01 GSKVX000000034795 Mk-1084 Glutenin Ipratropium Bromide Secukinumab Moxifloxacin Hydrochloride Adct-402 Daridorexant Carbidopa Agomelatine Buloxibutid Avibactam Sodium Valbenazine Ditosylate Pd01B Vutrisiran OMTX705 SEPOFARSEN NADOFARAGENE FIRADENOVEC More therapies…

    Learn about Your Condition

    Pharyngeal cancer stage III BK virus infection Erectile dysfunction Dizziness Back pain Autism spectrum disorder Renal transplant Renal cancer metastatic Thermal burn Intellectual disability Immune-mediated renal disorder Post procedural complication Iron deficiency Cancer fatigue Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Efficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Cabozantinib
    Austria Belgium Denmark France Germany Ireland +5

  • A study to compare how the body absorbs perampanel in healthy adult men and women during fasting conditions

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Perampanel
    Czechia

  • Bioequivalence Study of Amoxicillin/Clavulanic Acid Oral Suspension Compared with Reference Product in Healthy Adult Volunteers under Fed Conditions

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Heparin Sodium
    • Amoxicillin
    • Clavulanic Acid
    Czechia

  • A study comparing how midazolam oromucosal solution and midazolam solution for injection are absorbed in healthy volunteers

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Midazolam
    Portugal

  • A study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Nicotine dependence
    Investigated Drugs:
    • Cytisinicline
    Portugal Spain

  • Effect of itraconazole on the blood levels of BI 1815368 after a single oral dose in healthy male subjects

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Itraconazole
    Germany
Previous Page
1 … 928 929 930 931 932 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!